|
000
| 01468nas##2200301za#4500 |
|---|
| 001 | 9.514270 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210615082844 |
|---|
| 007 | ta |
|---|
| 008 | 150406c2002||||xxc|| p #||||f| |0eng|d |
|---|
| 022 | |a1499-9447 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-4/1E |
|---|
| 110 | 1 |aCanada. |bHealth Products and Food Branch. |
|---|
| 245 | 10|aCanadian adverse reaction newsletter / |cIssued by Marketed Health Products Directorate. |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |
|---|
| 310 | |aQuarterly |
|---|
| 362 | 1 |aVol. 12, issue 2 (Apr. 2002)-- |
|---|
| 500 | |aOther title: Canadian ADR newsletter. |
|---|
| 500 | |aContinues "Canadian adverse drug reaction newsletter" (ISSN 1204-9492, [Vol. 1, No. 1, 1991]-Vol. 12, No. 1, January 2002). |
|---|
| 520 | 3 |aA reputable source of adverse reaction information. Alerts health professionals to potential signals detected through the review of case reports submitted to Health Canada. It is a useful mechanism to disseminate information on suspected adverse reactions to health products occurring in humans before comprehensive risk-benefit evaluations and regulatory decisions are undertaken. |
|---|
| 563 | |aPamphlet |
|---|
| 690 | 07|aAdverse effects|2gcpds |
|---|
| 690 | 07|aHealth care products|2gcpds |
|---|
| 775 | 08|tBulletin canadien des effets indésirables / |w(CaOODSP)9.512691 |
|---|
| 776 | 0#|tCanadian adverse reaction newsletter |w(CaOODSP)9.505060 |
|---|